Isomorphic Labs vs Turnitin

Turnitin's core is plagiarism detection against a massive academic database, coupled with AI writing detection (Clarity) and secure exam tools (ExamSoft, Feedback Studio). It integrates deeply with LMS platforms like Canvas, Blackboard, and Moodle, targeting educators and institutions. In contrast, Isomorphic Labs leverages Nobel Prize-winning AlphaFold for drug discovery, with a new Drug Design Engine (launched July 2026) that generates novel molecules. Its predictive models simulate protein-ligand interactions, metabolism, and toxicity, but only through close partnerships with pharma giants like Novartis and Johnson & Johnson. Turnitin offers self-service via LMS; Isomorphic Labs has no API or standalone software—access is purely collaborative. Turnitin's latest news is absent; Isomorphic Labs recently announced a bioresilience framework for pandemic preparedness and a Series B round, signaling growth.

Both products require contacting sales, but their economic models differ vastly. Turnitin sells institutional licenses—pricing scales with student/teacher count and feature tiers (e.g., Clarity, Similarity, ExamSoft). It's designed for recurring budget lines at schools and universities. Isomorphic Labs operates as a partnership R&D firm: no per-user or per-use pricing. Costs are negotiated as part of multi-year drug development collaborations, likely involving equity, milestones, and royalties. There is no transparent pricing for either. For a cash-strapped individual or small team, Turnitin might be feasible via an institutional subscription; Isomorphic Labs is inaccessible without a pharma-scale checkbook. The closest to 'free' is nothing here—both expect significant investment.